Results
|
7061.
|
|
|
7062.
|
|
|
7063.
|
|
|
7064.
|
|
|
7065.
|
|
|
7066.
|
|
|
7067.
|
|
|
7068.
|
VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. [electronic resource] by
- Gautschi, Oliver
- Dingemans, Anne-Marie
- Crowe, Susanne
- Peters, Solange
- Roder, Heinrich
- Grigorieva, Julia
- Roder, Joanna
- Zappa, Francesco
- Pless, Miklos
- Brutsche, Martin
- Baty, Florent
- Bubendorf, Lukas
- Hsu Schmitz, Shu-Fang
- Na, Kyung-Jae
- Carbone, David
- Stahel, Rolf
- Smit, Egbert
Producer: 20130624
In:
Lung cancer (Amsterdam, Netherlands) vol. 79
Availability: No items available.
|
|
7069.
|
|
|
7070.
|
|
|
7071.
|
|
|
7072.
|
|
|
7073.
|
|
|
7074.
|
|
|
7075.
|
|
|
7076.
|
|
|
7077.
|
|
|
7078.
|
|
|
7079.
|
|
|
7080.
|
|